Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11666638 Glycotargeting therapeutics

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 20, 2019
0
Date of Patent
June 6, 2023
0
Patent Application Number
16723774
0
Patent Citations
‌
US Patent 9518087 Erythrocyte-binding therapeutics
0
‌
US Patent 10940209 Glycotargeting therapeutics
0
‌
US Patent 10946079 Glycotargeting therapeutics
0
‌
US Patent 10953101 Glycotargeting therapeutics
0
‌
US Patent 7132475 Block copolymers for multifunctional self-assembled systems
0
‌
US Patent 7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
0
‌
US Patent 7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10
0
‌
US Patent 7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
0
‌
US Patent 7285642 Composition and method for modulating dendritic cell-T cell interaction
0
‌
US Patent 7420041 Cytotoxicity mediation of cells evidencing surface expression of TROP-2
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11666638
0
Patent Primary Examiner
‌
Thea D'Ambrosio
0

Find more entities like US Patent 11666638 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo